The test involves exposing a sample of the patient’s blood cells to a chemical or radiation that damages DNA and induces chromosomal breaks. The cells are then evaluated for their ability to repair the breaks, as well as the frequency and type of breaks that occur. In patients with FA, the cells are unable to repair chromosomal breaks, resulting in an increased frequency of breaks and abnormal chromosomes.